» Articles » PMID: 15232722

Functionalization and Peptide-based Delivery of Magnetic Nanoparticles As an Intracellular MRI Contrast Agent

Overview
Publisher Springer
Specialty Biochemistry
Date 2004 Jul 3
PMID 15232722
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

We report the development of functionalized superparamagnetic iron oxide nanoparticles with a PEG-modified, phospholipid micelle coating, and their delivery into living cells. The size of the coated particles, as determined by dynamic light scattering and electron microscopy, was found to be between 12 and 14 nm. The PEG-phospholipid coating resulted in high water solubility and stability, and the functional groups of modified PEG allowed for bioconjugation of various moieties, including a fluorescent dye and the Tat peptide. Efficient delivery of the functionalized nanoparticles into living cells was confirmed by fluorescence microscopy, relaxation time measurements, and magnetic resonance imaging (MRI). This demonstrates the feasibility of using functionalized magnetic nanoparticles with uniform (approximately 10 nm) sizes as an MRI contrast agent for intracellular molecular imaging in deep tissue. These micelle-coated iron oxide nanoparticles offer a versatile platform for conjugation of a variety of moieties, and their small size confers advantages for intracellular molecular imaging with minimal perturbation.

Citing Articles

Application of HN-FeO Nanoparticles for Prostate Cancer Magnetic Resonance Imaging in an Animal Model.

Blasiak B, MacDonald D, Jasinski K, Cheng F, Tomanek B Int J Mol Sci. 2024; 25(19).

PMID: 39408664 PMC: 11477031. DOI: 10.3390/ijms251910334.


Therapeutic potential of lactoferrin-coated iron oxide nanospheres for targeted hyperthermia in gastric cancer.

Attri K, Chudasama B, Mahajan R, Choudhury D Sci Rep. 2023; 13(1):17875.

PMID: 37857677 PMC: 10587155. DOI: 10.1038/s41598-023-43725-3.


Electroactive nanoinjection platform for intracellular delivery and gene silencing.

Shokouhi A, Chen Y, Yoh H, Murayama T, Suu K, Morikawa Y J Nanobiotechnology. 2023; 21(1):273.

PMID: 37592297 PMC: 10433684. DOI: 10.1186/s12951-023-02056-1.


Extracellular vesicle-based biovectors in chronic wound healing: Biogenesis and delivery approaches.

Garima , Sharma D, Kumar A, Mostafavi E Mol Ther Nucleic Acids. 2023; 32:822-840.

PMID: 37273778 PMC: 10238601. DOI: 10.1016/j.omtn.2023.05.002.


Preparation of Self-Assembled Nanoparticle-Polymer Hybrids from Modified Silica Nanoparticles and Polystyrene-Block-Polyacrylic Acid Vesicles via the Co-Precipitation Method.

Mann J, Garnweitner G, Schilde C Polymers (Basel). 2023; 15(2).

PMID: 36679323 PMC: 9867192. DOI: 10.3390/polym15020444.


References
1.
Perkins W, Ahmad I, Li X, Hirsh D, Masters G, Fecko C . Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds. Int J Pharm. 2000; 200(1):27-39. DOI: 10.1016/s0378-5173(00)00329-x. View

2.
Torchilin V, Levchenko T, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B, DSouza G . Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A. 2003; 100(4):1972-7. PMC: 149943. DOI: 10.1073/pnas.0435906100. View

3.
Dyal A, Loos K, Noto M, Chang S, Spagnoli C, Shafi K . Activity of Candida rugosa lipase immobilized on gamma-Fe2O3 magnetic nanoparticles. J Am Chem Soc. 2003; 125(7):1684-5. DOI: 10.1021/ja021223n. View

4.
Lanza G, Abendschein D, Yu X, Winter P, Karukstis K, Scott M . Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology. Acad Radiol. 2002; 9 Suppl 2:S330-1. DOI: 10.1016/s1076-6332(03)80220-9. View

5.
Butler J, Kelly S . A model for cytoplasmic rheology consistent with magnetic twisting cytometry. Biorheology. 1999; 35(3):193-209. DOI: 10.1016/S0006-355X(99)80007-9. View